Earnings Season Sees Investors Sour on 'Omics Tools, MDx Firms | GenomeWeb

NEW YORK (GenomeWeb News) – As second-quarter financial reports continue to roll in, investors have been unimpressed with the results offered by many of the 'omics tools and molecular diagnostics firms that comprise the GenomeWeb Daily News Index.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.